Search results for "Castration"

showing 10 items of 50 documents

Second-Line Endocrine Treatment

1988

It was a milestone of cancer therapy in general when Huggins et al. [1] in 1941 first reported the beneficial clinical effects of bilateral orchiectomy in patients with prostate cancer, and the use of castration or estrogens as standard therapy remained the first- line treatment for many years. It was furthermore the beginning of a development which, over the following decades, led to the manipulation of testicular androgen synthesis and to attempts to eliminate other possible sources of male hormones.

Oncologymedicine.medical_specialtybusiness.industryCyproterone acetatemedicine.diseasechemistry.chemical_compoundProstate cancerAndrogen synthesisCastrationSecond linechemistryInternal medicinemedicineEndocrine systemMedroxyprogesterone acetatebusinessHormonemedicine.drug
researchProduct

The effects of castration and of progestin-oestrogen combinations upon avoidance condtioning in female rats

1970

Summary Using avoidance conditioning the authors show that female rats, three months after castration, emit a lower number of responses. Isolation has no effect whatever on rats, whether normal or castrated. Brief treatment with progestin-oestrogen combinations, interrupted 60 hours before the commencement of the session, brings the behaviour of castrated rats back to the norm. Identical effects occur with the use of a cortical stimulating drug (methylphenidate); while, the action of this drug soon ceases, the effect of hormonal treatment lasts for the duration of the experiments. The results are discussed with reference to the significance to be attributed to the experiments.

Pharmacologymedicine.medical_specialtyMethylphenidatemedicine.drug_classAvoidance Conditioningchemistry.chemical_compoundCastrationEndocrinologychemistryInternal medicinemedicineBrief treatmentPsychologyProgestinHormonemedicine.drugPharmacological Research Communications
researchProduct

Digenean parasites of the bivalve mollusc Pisidium amnicum in a small river in eastern Finland

1998

The host-parasite relationship between digeneans and a semelparous population of the mollusc. Pisidium amnicum Müller in a small river in eastern Finland was studied during 1992/1993. The parasite prevalence of the population was high. The total prevalence was 45.6% in 1992 (n = 790) and 47.5% in 1993 (n = 160). The dominant digenean, Bunodera luciopercae (34.2% in 1992, 35.0% in 1993), had highest prevalences in July/August and in winter. Two other species, Palaeorchis crassus (7.8% in 1992, 7.5% in 1993) and Phyllodistomum elongatum (4.7% and 5.0%), were rare during the winter. The prevalence of B. luciopercae increased as clams aged, while the other species were most common in middle-siz…

PopulationZoologyFresh WaterTrematode InfectionsDisease VectorsAquatic ScienceBiologyDigeneaHost-Parasite InteractionsFish DiseasesAnimalseducationMolluscaFinlandEcology Evolution Behavior and Systematicseducation.field_of_studyEcologyIntermediate hostBivalviabiology.organism_classificationParasitic castrationBivalviaPerciformesPisidium amnicumPerchesTrematodaTrematodaDiseases of Aquatic Organisms
researchProduct

Prospective computational design and in vitro bio-analytical tests of new chemical entities as potential selective CYP17A1 lyase inhibitors

2019

[EN] The development and advancement of prostate cancer (PCa) into stage 4, where it metastasize, is a major problem mostly in elder males. The growth of PCa cells is stirred up by androgens and androgen receptor (AR). Therefore, therapeutic strategies such as blocking androgens synthesis and inhibiting AR binding have been explored in recent years. However, recently approved drugs (or in clinical phase) failed in improving the expected survival rates for this metastatic-castration resistant prostate cancer (mCRPC) patients. The selective CYP17A1 inhibition of 17,20-lyase route has emerged as a novel strategy. Such inhibition blocks the production of androgens everywhere they are found in t…

Quantitative structure–activity relationshipStereochemistry01 natural sciencesBiochemistryStructure-Activity Relationship3D-QSAR pharmacophore modelDrug DiscoveryCytochrome P-450 Enzyme InhibitorsHumansStructure–activity relationshipCYP17A1 InhibitorMolecular BiologyDensity Functional TheoryVirtual screeningDose-Response Relationship DrugMolecular Structure010405 organic chemistryChemistryOrganic ChemistryProspective computational designSteroid 17-alpha-Hydroxylasecomputer.file_format1720-lyase selective inhibitionProtein Data BankLyase0104 chemical sciencesMolecular Docking Simulation010404 medicinal & biomolecular chemistryDocking (molecular)CYP17A1 inhibitorsMetastatic-castration resistant prostate cancerPharmacophorecomputer
researchProduct

Radium-223 treatment in castration resistant bone metastatic prostate cancer. Should be the primary tumor always treated?

2019

Introduction: Radium-223 (223Ra) improves symptoms and survival in patients with bone metastatic castration-resistant prostate cancer (mCRPC). Study aim: To evaluate the impact of a previous radical prostatectomy (RP) on the outcome of 223Ra therapy in mCRPC patients. The primary prostate tumor left untreated could progress during 223Ra treatment. Materials and methods: mCRPC symptomatic patients treated with 223Ra were enrolled. Luteinizing Hormone-Releasing Hormone analogue was maintained. No other anticancer therapy was given. 223Ra was administered i.v. at the dose of 55 kBq/kg every 4 weeks for 6 cycles. Patients were stratified according to previous RP or not. Hematological toxicity w…

Radium-223Malemedicine.medical_specialtyUrologymedicine.medical_treatment030232 urology & nephrologyUrologyAntineoplastic AgentsBone NeoplasmsSettore MED/24 - UrologiaPrimary tumor03 medical and health sciencesProstate cancer0302 clinical medicineProstateRadium-222medicineHumansAgedProstatectomyRadiotherapybusiness.industryProstatectomyProstateChemoradiotherapy Adjuvantmedicine.diseasePrognosisRadical prostatectomyPrimary tumorSurvival AnalysisRadiation therapyProstatic Neoplasms Castration-Resistantmedicine.anatomical_structureTreatment OutcomeOncology030220 oncology & carcinogenesisConcomitantDisease ProgressionCastration resistant prostate cancerNeoplasm GradingRadiopharmaceuticalsbusinessmedicine.drugHormoneFollow-Up StudiesRadiumUrologic oncology
researchProduct

Aneuploidy as a consequence of senescence and ovariectomy in the golden hamster (Mesocricetus auratus).

1978

The hypothesis of the preferred X-chromosome loss in elder human females was reevaluated in the golden hamster: early castration of females proved that the increase of aneuploid cells is correlated with the loss of the ovaries. But here, and in old females, aneuploidy consisted of random loss of excess of chromosomes, in no case an X-chromosome.

Senescencemedicine.medical_specialtyAgingX ChromosomeAneuploidyBone Marrow CellsBiologyAndrologyCellular and Molecular Neurosciencechemistry.chemical_compoundInternal medicineCricetinaemedicineAnimalsCastrationMolecular BiologyX chromosomePharmacologyCell Biologymedicine.diseasebiology.organism_classificationAneuploidyEndocrinologyCastrationchemistryMolecular MedicineAneuploid CellsFemaleHuman FemalesMesocricetusGolden hamsterExperientia
researchProduct

A research on the action of testosterone propionate and of ciproterone acetate on the mouse-killing behaviour of the adult rat.

1979

AbstractData demonstrate exactly that testosterone favour above all the killing behaviour of castrate males at birth in comparison with control males while ciproterone acetate turns out to be more effective in diminishing the killing behaviour of males having integral testicle and of androgenized females at birth in comparison with castrated males.The results point out that the killing behaviour of rats is affected by the presence of testosterone in the first days of life, and in the grown-up animal.

Testosterone propionateMalemedicine.medical_specialtyPhysiologyBiologyMouse killingTesticleBiochemistryRatsAggressionchemistry.chemical_compoundMiceEndocrinologymedicine.anatomical_structureSex FactorschemistryInternal medicinemedicineAnimalsHumansFemaleTestosteroneCastrationCyproteroneTestosteroneArchives internationales de physiologie et de biochimie
researchProduct

Changes of the hindgut microbiota due to high-starch diet can be associated with behavioral stress response in horses.

2015

6 pages; International audience; The digestive system of horses is adapted to a high-fiber diet consumed in small amounts over a long time. However, during training, high-starch and low-fiber diets are usually fed which may induce hindgut microbial disturbances and intestinal pain. These diets can be described as alimentary stress. The aim of the present study was to investigate to what extent changes in behavior are associated with alimentary stress and microbial composition changes of the cecal or colonic ecosystem. Six fistulated horses were used. The alimentary stress was a modification of diet from a high-fiber diet (100% hay) to a progressive low-fiber and high-starch diet (from 90% h…

Time Factors040301 veterinary sciencesmedia_common.quotation_subjectExperimental and Cognitive PsychologyBiology0403 veterinary scienceBehavioral NeuroscienceHorse behaviormedicine[ SDV.EE.IEO ] Life Sciences [q-bio]/Ecology environment/SymbiosisDietary CarbohydratesIntestinal FistulaAnimalsAlimentary stressFood scienceCastrationLongitudinal StudiesHorsesSocial BehaviorCecummedia_common2. Zero hunger[ SDE.BE ] Environmental Sciences/Biodiversity and EcologyAnalysis of VarianceBehaviorMicrobiotaNeophobia0402 animal and dairy scienceHorseHindgutStarch04 agricultural and veterinary sciencesFeeding Behaviormedicine.disease040201 dairy & animal scienceBlood Cell CountDietHayExploratory BehaviorAnaerobic bacteria[SDE.BE]Environmental Sciences/Biodiversity and EcologyAnaerobic exerciseStress PsychologicalVigilance (psychology)[SDV.EE.IEO]Life Sciences [q-bio]/Ecology environment/Symbiosis
researchProduct

Effect of starvation on parasite-induced mortality in a freshwater snail (Potamopyrgus antipodarum).

1999

The level of host exploitation is expected, under theory, to be selected to maximise (subject to constraints) the lifetime reproductive success of the parasite. Here we studied the effect of two castrating trematode species on their intermediate snail host, Potamopyrgus antipodarum. One of the trematode species, Microphallus sp., encysts in the snail host and the encysted larvae “hatch” following ingestion of infected snails by birds. The other species, Notocotylus gippyensis, by contrast, releases swimming larvae; ingestion of the snail host is not required for, and does not aid, transmission to the final host. We isolated field-collected snails for 3 months in the laboratory, and followed…

biologyEcologyPotamopyrgusfungiZoologyParasitismSnailbiology.organism_classificationParasitic castrationFreshwater snailbiology.animalparasitic diseasesMicrophallusTrematodaEcology Evolution Behavior and SystematicsPotamopyrgus antipodarumOecologia
researchProduct

Value of Combined PET Imaging with [18F]FDG and [68Ga]Ga-PSMA-11 in mCRPC Patients with Worsening Disease during [177Lu]Lu-PSMA-617 RLT

2021

Despite the promising results of prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (RLT) in metastatic castration-resistant prostate cancer (mCRPC), some patients show worsening disease during PSMA-RLT. We investigated the value of combined [18F]FDG and [68Ga]Ga-PSMA-11 PET imaging in this setting. In n = 29 mCRPC patients with worsening disease after a median of four cycles of [177Lu]Lu-PSMA-617 RLT, combined [18F]FDG and [68Ga]Ga-PSMA-11 PET imaging was performed to detect [18F]FDG-avid lesions with low or no PSMA expression (mismatch lesions). To evaluate prognostic implication of mismatch, survival analyses regarding presence, location, and [18F]FDG PET-derived para…

radioligand therapy; PSMA; FDG; PET/CT; mismatch; metastatic castration-resistant prostate cancerCancer Researchmedicine.medical_specialtyFDGPET/CTUrology610Diseaseurologic and male genital diseasesMetastasisProstate cancerPSMAmedicineRC254-282Membrane antigenPET-CTbusiness.industryNeoplasms. Tumors. Oncology. Including cancer and carcinogensPet imagingMetabolic tumor volumemedicine.diseaseradioligand therapyTotal lesion glycolysismetastatic castration-resistant prostate cancerOncologybusinessmismatchCancers
researchProduct